Ikarian Capital, LLC Clene Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.1 - $4.12 $932,994 - $1.83 Million	-444,283 Reduced 86.39%	70,000 $177,000
Q1 2022 May 13, 2022	BUY	$2.42 - $4.42 $60,408 - $110,332	24,962 Added 5.1%	514,283 $2.03 Million
Q3 2021 Nov 15, 2021	BUY	$6.83 - $13.58 $2.53 Million - $5.04 Million	370,788 Added 312.81%	489,321 $3.34 Million
Q1 2021 May 17, 2021	BUY	$6.39 - $16.3 $757,425 - $1.93 Million	118,533 New	118,533 $1.52 Million

230K

25K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $318M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.